Calidi Biotherapeutics Appoints New CEO and Advances Systemic Virotherapy Platform
Calidi Biotherapeutics appoints Eric Poma, Ph.D., as CEO, signaling strategic shift towards later-stage clinical development. Company's technology targeting solid tumors could revolutionize oncology treatments.
This news matters as it highlights a significant leadership change at Calidi Biotherapeutics, signaling a strategic shift towards later-stage clinical development. The company's innovative technology in combating cancer and targeting solid tumors could have a profound impact on oncology treatments and patient outcomes.